Search - tctmd.com

Displaying 301 - 320 of 372

Sort: Relevancy | Date

News Conference News TCT 2014

Marie-Claude Morice, MD, Receives 2014 Master Clinical Operator Award

September 15, 2014

News Conference News TCT 2014

Capture Devices Hold Promise for Decreasing TAVR-Related Stroke

September 15, 2014

Presentation TCT 2014

No: Vorapaxar Is Effective, but Prasugrel and Ticagrelor are Preferred!

Presenter: Dirk Sibbing

September 14, 2014

Presentation TCT 2014

Yes: TRA-2P Has Proven it!

Presenter: David J. Moliterno

September 14, 2014

Presentation TCT 2014

Integrating a WOEST Aspirin Deletion Strategy Into Clinical Practice: When Is it Appropriate?

Presenter: Robert A. Harrington, Ajay J. Kirtane, Thomas D. Stuckey, Freek W.A. Verheugt

September 14, 2014

Presentation TCT 2014

NO: Cangrelor Is No Champion Next to the Appropriate Use of Potent Oral Antiplatelet Agents!

Presenter: Dimitrios Alexopoulos

September 14, 2014

Presentation TCT 2014

YES: CHAMPION PHOENIX was Convincing!

Presenter: Deepak L. Bhatt

September 14, 2014

Presentation TCT 2014

Yes: WOEST Definititely Proves Safety and Likely Efficacy as Well!

Presenter: Harvey D. White

September 14, 2014

Presentation TCT 2014

Featured Lecture: Aspirin, the Most Understood and Misunderstood Antiplatelet Agent

Presenter: Robert A. Harrington, Ajay J. Kirtane, Thomas D. Stuckey, Anthony A. Bavry

September 14, 2014

Presentation TCT 2014

Can LAA Closure Become the New Standard for Stroke Prevention?

Presenter: Hilary Nierenberg, Julie Logan, Saibal Kar

September 14, 2014

Presentation TCT 2014

Prevention of Stent Thrombosis: Devices, Pharmacology, Technique, Patients, and More

Presenter: Stephen G. Ellis, Patrick W. Serruys, Elvin Kedhi, Lorenz Raber

September 14, 2014

Presentation TCT 2014

Aspirin and ADP Antagonists Before and After Coronary Stent Implantation

Presenter: Paul A. Gurbel, Dmitriy N. Feldman

September 14, 2014

News Conference News TCT 2014

TCT Keynote: Global Vision for Prevention in Children and Adults Could Change CVD Landscape

September 14, 2014

News Conference News TCT 2014

LAA Closure Edges Out Medical Therapy for Cost-effectiveness in AF

September 14, 2014

News Conference News TCT 2014

Meta-analysis: Less Bleeding, More Stent Thrombosis with Bivalirudin vs. Heparin After PCI

September 13, 2014

News Conference News TCT 2013

Triple Antiplatelet Therapy with Cilostazol Increases Tachycardia, Arrhythmias

November 04, 2013

Presentation TCT 2013

How the Cardiologist Can Help in Stroke Prevention

Presenter: Leo Nelson Hopkins

October 31, 2013

News Conference News TCT 2013

TCT Leadership Outlines the State of Intervention

October 30, 2013

Presentation TCT 2013

Prevention of Contrast Induced Acute Kidney Injury wtih Ascorbic Acid

Presenter: Umar Sadat

October 30, 2013

Presentation TCT 2013

Neurological Complications of TEVAR: Prevention and Management

Presenter: Michael Dake

October 30, 2013

Advertisement

Marie-Claude Morice, MD, Receives 2014 Master Clinical Operator Award

Capture Devices Hold Promise for Decreasing TAVR-Related Stroke

No: Vorapaxar Is Effective, but Prasugrel and Ticagrelor are Preferred!

Yes: TRA-2P Has Proven it!

Integrating a WOEST Aspirin Deletion Strategy Into Clinical Practice: When Is it Appropriate?

NO: Cangrelor Is No Champion Next to the Appropriate Use of Potent Oral Antiplatelet Agents!

YES: CHAMPION PHOENIX was Convincing!

Yes: WOEST Definititely Proves Safety and Likely Efficacy as Well!

Featured Lecture: Aspirin, the Most Understood and Misunderstood Antiplatelet Agent

Can LAA Closure Become the New Standard for Stroke Prevention?

Prevention of Stent Thrombosis: Devices, Pharmacology, Technique, Patients, and More

Aspirin and ADP Antagonists Before and After Coronary Stent Implantation

TCT Keynote: Global Vision for Prevention in Children and Adults Could Change CVD Landscape

LAA Closure Edges Out Medical Therapy for Cost-effectiveness in AF

Meta-analysis: Less Bleeding, More Stent Thrombosis with Bivalirudin vs. Heparin After PCI

Triple Antiplatelet Therapy with Cilostazol Increases Tachycardia, Arrhythmias

How the Cardiologist Can Help in Stroke Prevention

TCT Leadership Outlines the State of Intervention

Prevention of Contrast Induced Acute Kidney Injury wtih Ascorbic Acid

Neurological Complications of TEVAR: Prevention and Management

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content